edited by
and
All Danish bladder cancer patients are reported to the central Danish Cancer Registry. About 1500 new cases are diagnosed yearly, giving a bladder tumor incidence of 25 per 100.000 habitants. Bladder tumor is the forth most common tumor in men and the tenth most common in woman. A regional Danish Bladder Cancer Registry comprising 800 patients with primary bladder tumors from 2 university departments showed that 48% of the new cases had non-invasive and 52% invasive tumor. Only 6% of the patients with non-invasive tumors progressed to invasive disease.
A recent report from the National Cancer Registries in the Nordic countries indicated a poorer survival of Danish patients with bladder tumor compared with Nowegian, Swedish, Finish and Icelandic patients. Therefore, the National Danish Bladder Registry (DBCR) was established to evaluate the bladder tumor disease in Denmark. The registry includes data from all patients in Denmark with bladder tumor (invasive or non-invasive) diagnosed after January 1, 2000.
Data is obtained from the National Pathology Registry and the Central
Person Registry (CPR). Whenever a bladder tumor specimen or cytology specimen is examined
by a pathologist in any Danish hospital the code describing the specimen and diagnosis is
recorded in the National Pathology Registry. The Central Person Registry includes names,
vital status and a unique person identification code for all persons with a permanent
residence in Denmark. DBCR is updated yearly with data on newly diagnosed patients and
follow-up data on previously recorded patients.
Danish Bladder Cancer Registry
Att. Gregers Gautier Hermann
MD, DM Sc, FEBU
Clinical Research Unit,
54B1
E-mail DBCR
Herlev Hospital
DK-2730 Herlev
Copenhagen, Denmark
November 1, 1999
This page was last edited November 21, 1999